Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120097) titled 'Sirolimus for the Treatment of Refractory Immune Checkpoint Inhibitor-Related Liver Injury: A Single-Arm Exploratory Study' on March 9.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The Third Affiliated Hospital of Sun Yat-sen University
Condition:
Immune-mediated Liver Injury from Checkpoint Inhibitors, ILICI
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-03-10
Target Sample Size: Treatment group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=307250
Published by HT Digital Content Servi...